Eligard Adverse Event Report 2018

$19.99

This report includes data from the FDA’s Adverse Events Reports for 2018.  We removed reports where the subject of the report was taking only this drug. This report provides the following fields:

  • ID
  • Patient Summary
  • Patient Gender
  • Patient Age
  • Drug Products
  • Drug Reactions
Categories: ,

Description

Eligard (leuprolide) overstimulates the body’s own production of certain hormones, which causes that production to shut down temporarily. Leuprolide reduces the amount of testosterone in men or estrogen in women. Eligard injectable suspension is used in men to treat the symptoms of prostate cancer. Eligard treats only the symptoms of prostate cancer and does not treat the cancer itself. https://www.drugs.com/eligard.html

Related products

Contact US

484-352-2642

Contact Us

Learn More

What is an Adverse Event Report?

The FDA Adverse Event Reporting System (FAERS) is a database that contains adverse event reports, medication error reports and product quality complaints resulting in adverse events that were submitted to FDA.